Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 156-168
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.156
Renal dysfunction in patients with cirrhosis: Where do we stand?
Chrysoula Pipili, Evangelos Cholongitas
Chrysoula Pipili, Department of Nephrology, Laiki Merimna, 17343 Athens, Greece
Evangelos Cholongitas, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 54642 Thessaloniki, Greece
Author contributions: Pipili C and Cholongitas E contributed equally to this paper.
Correspondence to: Evangelos Cholongitas, Senior Lecturer of Internal Medicine, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Telephone: +30-23-10892110 Fax: +30-23-10992940
Received: December 10, 2013
Revised: February 8, 2014
Accepted: May 8, 2014
Published online: August 6, 2014
Processing time: 268 Days and 1.9 Hours
Core Tip

Core tip: Close surveillance, well -classified definitions and scoring systems will be helpful in recognizing the renal dysfunction. Noninvasive biomarkers (NGAL, sCysC) reflect the prospective method in identifying kidney damage and kidney function. The acute renal function is proposed to be assessed with modified acute kidney injury network (AKIN) and the baseline renal function in stable patients with MDRD-6 formula or chronic kidney disease epidemiology collaboration Cys C-Cr equation. MBRS score or RIFLE criteria for AKI evaluation should be tried in critically ill cirrhotic patients, while in candidates for transplantation, glomerular filtration rate should be preferably measured with exogenous markers for accurate assessment of renal function. Amelioration of the underlined liver disease is very impressive in patients with alcoholic liver disease after recovery from alcoholic hepatitis, and in patients with decompensated cirrhosis due to hepatitis B virus infection after receiving antiviral therapy.